(2021) (5) concluded that in cancer cells, a potential mechanism of action of Caerin 1.1 is to inactivate the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway and inhibit its overexpression or its mutant signal components, thereby promoting cell apoptosis. This evidence concerns the gene AKT1 and cancer.